Salmonella enterica subspecies enterica serotype Typhimurium phage type DT104 (DT104) can infect both humans and animals and is often multidrug-resistant (MDR). Previous studies have indicated that, unlike most S. Typhimurium, the overwhelming majority of DT104 strains produce a pertussis-like toxin, ArtAB, via prophage-encoded artAB; however, DT104 that lack artAB have been described on occasion. Here, we identify a MDR DT104 lineage circulating among humans and cattle in the United States, which lacks artAB (i.e., the “U.S. artAB-negative major clade”; n = 41 genomes). Unlike most other bovine- and human-associated DT104 strains from the U.S. (n = 219 total genomes), which harbor artAB on prophage Gifsy-1 (n = 167), members of the U.S. artAB-negative major clade lack Gifsy-1, as well as anti-inflammatory effector gogB. The U.S. artAB-negative major clade was predicted to have lost artAB, Gifsy-1, and gogB circa 1993-1995 (95% highest posterior density interval 1989.5-1997.7), in close temporal proximity to a predicted rapid increase in the U.S. DT104 effective population size (circa 1996). When compared to DT104 genomes from other world regions (n = 752 total genomes), several additional, sporadic artAB, Gifsy-1, and/or gogB loss events among clades encompassing ≤5 genomes were observed. In phenotypic assays that simulate conditions encountered during human and/or bovine digestion, members of the U.S. artAB-negative major clade did not differ from closely related Gifsy-1/artAB/gogB-harboring U.S. DT104 strains (ANOVA raw P > 0.05); thus, future research is needed to elucidate the roles that artAB, gogB, and Gifsy-1 play in DT104 virulence in humans and animals.Impact StatementMulti-drug resistant (MDR) Salmonella enterica serotype Typhimurium phage type DT104 (DT104) was responsible for a global epidemic among humans and animals throughout the 1990s and continues to circulate worldwide. Previous studies have indicated that the vast majority of DT104 produce a pertussis-like toxin, ArtAB, via prophage-encoded artAB. However, here we identify a DT104 lineage circulating among cattle and humans across ≥10 U.S. states, which lacks the ability to produce ArtAB (i.e., the “U.S. artAB-negative major clade”). The common ancestor of all U.S. artAB-negative major clade members lost the ability to produce ArtAB in close temporal proximity to the global MDR DT104 epidemic; however, the reason for this loss-of-function event within this well-established pathogen remains unclear. The role that ArtAB plays in DT104 virulence remains elusive, and phenotypic assays conducted here indicate that members of the U.S. artAB-negative major clade do not have a significant advantage or disadvantage relative to closely related Gifsy-1/artAB/gogB-harboring U.S. DT104 strains when exposed to stressors encountered during human and/or bovine digestion in vitro. However, ArtAB heterogeneity among DT104 suggest clade-specific selection for or against maintenance of ArtAB. Thus, future studies querying the virulence potential of the U.S. artAB- negative major clade are needed.Data SummaryThe authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.